386 related articles for article (PubMed ID: 27913470)
41. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
42. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
43. The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation.
Malard F; Jenq RR
Cancer J; 2023 Mar-Apr 01; 29(2):75-83. PubMed ID: 36957977
[TBL] [Abstract][Full Text] [Related]
44. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
45. Interactions of the microbiota with the mucosal immune system.
Bain CC; Cerovic V
Immunology; 2020 Jan; 159(1):1-3. PubMed ID: 31777065
[TBL] [Abstract][Full Text] [Related]
46. [Disruption of gut immune system caused by damage of intestinal stem cells and their niche in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.].
Hayase E; Teshima T
Clin Calcium; 2017; 27(6):829-833. PubMed ID: 28536321
[TBL] [Abstract][Full Text] [Related]
47. Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation.
Calabrese E; Zorzi F; Visconti E; De Angelis G; Cerretti R; Del Vecchio Blanco G; Picardi A; Cudillo L; Postorino M; Franceschini L; Biancone L; Arcese W; Pallone F
Dig Liver Dis; 2013 Nov; 45(11):899-904. PubMed ID: 23680035
[TBL] [Abstract][Full Text] [Related]
48. In this issue: Effect of gut microbiome on mucosal immunity and enteric diseases.
Kumar H; Bot A
Int Rev Immunol; 2018 Mar; 37(2):77-78. PubMed ID: 29558285
[No Abstract] [Full Text] [Related]
49. [Key players in intestinal GVHD].
Hashimoto D; Teshima T
Rinsho Ketsueki; 2015 Jul; 56(7):807-14. PubMed ID: 26251143
[TBL] [Abstract][Full Text] [Related]
50. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
Goldberg J; Jacobsohn DA; Zahurak ML; Vogelsang GB
Biol Blood Marrow Transplant; 2005 Feb; 11(2):101-7. PubMed ID: 15682070
[TBL] [Abstract][Full Text] [Related]
51. Mucosal immune responses to fungi and the implications for inflammatory bowel disease.
Limon JJ; Kershaw KM; Underhill DM
Curr Opin Gastroenterol; 2018 Nov; 34(6):398-403. PubMed ID: 30299290
[TBL] [Abstract][Full Text] [Related]
52. The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.
Legoff J; Resche-Rigon M; Bouquet J; Robin M; Naccache SN; Mercier-Delarue S; Federman S; Samayoa E; Rousseau C; Piron P; Kapel N; Simon F; Socié G; Chiu CY
Nat Med; 2017 Sep; 23(9):1080-1085. PubMed ID: 28759053
[TBL] [Abstract][Full Text] [Related]
53. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
54. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors.
Penack O; Holler E; van den Brink MR
Blood; 2010 Mar; 115(10):1865-72. PubMed ID: 20042727
[TBL] [Abstract][Full Text] [Related]
55. Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8.
Ara T; Hashimoto D; Hayase E; Noizat C; Kikuchi R; Hasegawa Y; Matsuda K; Ono S; Matsuno Y; Ebata K; Ogasawara R; Takahashi S; Ohigashi H; Yokoyama E; Matsuo K; Sugita J; Onozawa M; Okumura R; Takeda K; Teshima T
Sci Transl Med; 2020 Jul; 12(550):. PubMed ID: 32611682
[TBL] [Abstract][Full Text] [Related]
56. Intestinal graft-versus-host disease: mechanisms and management.
Takatsuka H; Iwasaki T; Okamoto T; Kakishita E
Drugs; 2003; 63(1):1-15. PubMed ID: 12487619
[TBL] [Abstract][Full Text] [Related]
57. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
[TBL] [Abstract][Full Text] [Related]
58. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
59. Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability.
Nalle SC; Zuo L; Ong MLDM; Singh G; Worthylake AM; Choi W; Manresa MC; Southworth AP; Edelblum KL; Baker GJ; Joseph NE; Savage PA; Turner JR
J Clin Invest; 2019 Feb; 129(2):902-914. PubMed ID: 30667372
[TBL] [Abstract][Full Text] [Related]
60. Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantation.
Krishna SG; Barlogie B; Lamps LW; Krishna K; Aduli F; Anaissie E
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):E17-21. PubMed ID: 20223723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
